Trending

Amryt Pharma

Amryt to expand rare disease portfolio with $311m Aegerion merger

Amryt to expand rare disease portfolio with $311m Aegerion merger

Rare disease specialist Amryt Pharma plans to expand its rare disease portfolio with the acquisition of troubled Aegerion

X

Amryt to expand rare disease portfolio with $311m Aegerion merger

https://pharmaphorum.com/news/amryt-to-expand-rare-disease-portfolio-with-311m-aegerion-merger/

Amryt looking to expand rare disease franchise

Amryt looking to expand rare disease franchise

Amryt looking to expand rare disease franchise

X

Amryt looking to expand rare disease franchise

https://pharmaphorum.com/news/amryt-looking-expand-rare-disease-franchise/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com